Результаты поиска

Donor Evaluation for Hematopoietic Stem and Progenitor Cell Collection

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Chemotherapy including tamoxifen unless taking for cancer prevention Chemotherapy including tamoxifen unless taking for cancer prevention Thyroid hormone replacement medication (not for cancer), if well-controlled Oral diabetic medications including chlorpropamide, tolbutamide, tolazamide, glipizide, glyburide … Chemotherapy including tamoxifen unless taking for cancer prevention | Chemotherapy including tamoxifen unless taking for cancer prevention Thyroid hormone replacement medication (not for cancer), if well-controlled | Oral diabetic medications including chlorpropamide, tolbutamide, tolazamide, glipizide, glyburide …

Идентификация NLRP3PYD Homo-Oligomerization Inhibitors с антивоспалительной активностью.

Инфламасомы представляют собой многопротеиновые комплексы, которые представляют собой важнейшие элементы подстрекательской реакции. Регулирование дискриминированного комплекса NLRP3 инфламасома связано с патогенезом таких заболеваний, как множественный склероз, тип 2 сахарный диабет, болезнь Альцгеймера и рак. Несмотря на наличие молекулярных ингибиторов, специфичных для различных компонентов воспламенительных комплексов, в настоящее время ни о каких ингибиторах не сообщается конкретно для NLRP3PYD гомо-олигомеризации. В настоящем исследовании мы описываем идентификацию QM380 и QM381 в качеств

Совпадение в полном тексте источника
… Indirect inhibitors of NLRP3 inflammasome activation include Glyburide, Bay 11-7082, β-hydroxybutyrate, VX-740, and JC124, which function by inhibiting ATP-sensitive K + channels, inhibiting the NF-κB pathway by inhibiting the kinase activity of IKKβ, K + efflux, blocking caspase-1 and reducing the …

An approach to treating older adults with chronic kidney disease.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… antagonists | Spironolactone, eplerenone Sodium–glucose cotransporter 2 inhibitors | Empagliflozin, dapagliflozin, canagliflozin Diuretics | Thiazides: indapamide, hydrochlorothiazide Loop diuretics: furosemide NSAIDs | Naproxen, ibuprofen, diclofenac Biguanide antidiabetic agent | Metformin Sulfonylureas | Glyburide …

Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanism.

The effects of tetraethylammonium (TEA), a K+ channel antagonist, on vasodilator responses were investigated in the hindquarters vascular bed of the cat under constant-flow conditions. After administration of TEA in a total dose of 60 mg/kg into the hindquarters perfusion circuit, vasodilator responses to acetylcholine, bradykinin, and substance P were reduced, whereas vasodilator responses to the NO donors, diethylamine-NO complex, S-nitroso-N-acetylpenicillamine, and sodium nitroprusside, and to prostaglandin E1, albuterol, vasoactive intestinal polypeptide, isradipine, and levcromakalim wer

Выявляется высокий уровень использования медицинских услуг после операции на шейном позвоночнике с использованием комплексных методов прогнозирования.

Расходы на медицинское обслуживание пациентов с хроническими заболеваниями позвоночника и пациентов, проходящих хирургическую операцию, продолжают расти заметными темпами. Таким образом, выявление пациентов, подверженных риску в плане более широкого использования послеоперационного медицинского обслуживания, имеет решающее значение для оптимизации результатов медицинского обслуживания и распределения ресурсов. Цель нашего исследования заключается в использовании целого ряда предоперабельных характеристик пациентов, включая всеобъемлющую медицинскую, хирургическую и социальную историю, для разр

Совпадение в полном тексте источника
… isophane” | Oral diabetes meds | “acarbose”, “miglitol”, “metformin”, “alogliptin”, “linagliptin”, “saxagliptin”, “sitagliptin”, “nateglinide”, “repaglinide”, “canagliflozin”, “dapagliflozin”, “empagliflozin”, “ertugliflozin”, “bexagliflozin”, “glimepiride”, “glipizide”, “tolazamide”, “tolbutamide”, “glyburide …

Revolutionary drug repositioning: the preventive and therapeutic potential of metformin and other antidiabetic drugs in age-related macular degeneration.

Age-related macular degeneration (AMD) is a leading cause of blindness among the elderly worldwide. Anti-vascular endothelial growth factor (anti-VEGF) injections remain the first-line therapy for AMD. However, their high cost and the need for frequent administration pose challenges to long-term adherence, highlighting the need for accessible and cost-effective preventive strategies. Emerging evidence suggests that traditional antidiabetic drugs, such as metformin, sulfonylureas, and thiazolidinediones, may offer neuroprotective benefits, opening new avenues for AMD prevention. Among these, me

Совпадение в полном тексте источника
… Glyburide confers neuroprotection against age-related macular degeneration (AMD) . Transl. Res. 272 , 81 – 94 . 10.1016/j.trsl.2024.05.002 38815899 Puglia C. Santonocito D. Romeo G. Intagliata S. Romano G. L. Strettoi E. ( 2021 ). …

Targeting the NLRP3 inflammasome in kidney disease: molecular mechanisms, pathogenic roles, and emerging small-molecule therapeutics.

Inflammatory responses represent a core pathological process driving the progression of both acute and chronic kidney diseases. As a key effector of the innate immune system, the NLRP3 inflammasome is widely activated in renal resident cellsand infiltrating immune cells, positioning it as a critical nexus linking metabolic dysregulation, cellular stress, and tissue injury. Accumulating preclinical and clinical evidence in recent years demonstrates that aberrant activation of the NLRP3 inflammasome directly promotes glomerular damage, tubulointerstitial inflammation, fibrosis, and vascular dysf

Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery.

Diabetes mellitus is an endocrine disorder characterized by prolonged hyperglycemia. It results from either insulin deficiency (type 1 diabetes mellitus, T1DM) or insulin resistance (type 2 diabetes mellitus, T2DM). This condition has emerged as a significant health concern in recent years. Hyperglycemia induces the overproduction of reactive oxygen species (ROS), which can modulate multiple pathways, including AGEs-RAGE, PKC stimulation, NF-κB and PI3K/AKT. These pathways contribute to diabetes-related complications such as inflammation, oxidative stress, insulin resistance, and reduced gluco

Совпадение в полном тексте источника
… One randomized controlled trial demonstrated that co-administering curcumin (475 mg/day) with glyburide enhanced the latter’s bioavailability through P-glycoprotein inhibition while maintaining unchanged peak plasma concentrations. …

Secretion of ATP from Schwann cells in response to uridine triphosphate.

The mechanisms by which uridine triphosphate (UTP) stimulates ATP release from Schwann cells cultured from the sciatic nerve were investigated using online bioluminescence techniques. UTP, a P2Y(2) and P2Y(4) receptor agonist, stimulated ATP release from Schwann cells in a dose-dependent manner with an ED(50) of 0.24 microm. UTP-stimulated ATP release occurs through P2Y(2) receptors as it was blocked by suramin which inhibits P2Y(2) but not P2Y(4) receptors. Furthermore, positive immunostaining of P2Y(2) receptors on Schwann cells was revealed and GTP, an equipotent agonist with UTP at rat P2Y

The Impact and Safety of GLP-1 Agents and Breast Cancer.

IntroductionObesity and breast cancer rates are increasing globally, with obesity prevalence more than doubling since 1990. By 2022, 44% of women were overweight, and 18% were obese. Breast cancer remains the most common malignancy among women, with 2.2 million new cases in 2020. A significant proportion of breast cancer patients are overweight or obese at diagnosis, which is associated with higher recurrence and mortality rates. Recently, GLP-1 receptor agonists (GLP-1 RAs) have emerged as remarkably effective weight loss drugs. Understanding the relationship between obesity, breast cancer, a

Совпадение в полном тексте источника
… Arnold Chan , “ Use of a Claims‐Based Active Drug Safety Surveillance System to Assess the Risk of Acute Pancreatitis With Exenatide or Sitagliptin Compared to Metformin or Glyburide ,” Current Medical Research and Opinion 25 ( 2009 ): 1019 – 1027 . 19278373 10.1185/03007990902820519 70 D. …

Metformin and Its Benefits for Various Diseases.

Metformin is a widely used biguanide drug due to its safety and low cost. It has been used for over 60 years to treat type 2 diabetes at the early stages because of its outstanding ability to decrease plasma glucose levels. Over time, different uses of metformin were discovered, and the benefits of metformin for various diseases and even aging were verified. These diseases include cancers (e.g., breast cancer, endometrial cancer, bone cancer, colorectal cancer, and melanoma), obesity, liver diseases, cardiovascular disease, and renal diseases. Metformin exerts different effects through differe

Совпадение в полном тексте источника
… Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. (2006) 355:2427–43. 10.1056/NEJMoa066224 25. Charpentier G, Fleury F, Kabir M, Vaur L, Halimi S. Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. …

Поврежденное когнитивное и поведенческое функционирование в детском возрасте и экономические результаты взрослой жизни.

Метформин был назван следующим: one :: из наиболее важных медицинских агентов первой линии в управлении типом 2 Болит диабет. Поскольку метформин является главным образом антигипергликемическим агентом, он также оказывает огромное влияние на различные системы и процессы. Он действует главным образом путем активации AMPK (Adenosine Monophosphate-Activated Protein Kinase) в клетках и сокращения выхода глюкозы из печени. Кроме того, она сокращает производство современных продуктов гликации и реактивных видов кислорода в эндотелии, помимо регулирования глюкозы и липидного метаболизма в кардиомиоки

Совпадение в полном тексте источника
… Kahn et al conducted a study in 4360 patients with diabetes over four years and found that oral hypoglycaemic agent rosiglitazone and glyburide cause weight gain of 4.8 and 1.6 kg respectively over a period, while metformin causes weight loss of 2.7 kg. 194 However, a meta analysis by Pinto et al showed …

A geriatrician's approach to managing the complex older adult with obesity.

The prevalence of obesity in older adults is rapidly increasing due to the demographic shift occurring globally. Older adults with obesity face health care challenges due to multimorbidity, functional dependency, and disability. This population often has prior history of struggles through weight-loss attempts during the middle years of life. Therefore, weight-loss intervention needs a personalized approach, taking into consideration weight-loss attempts, relapse, and life events, including bariatric surgery, functional limitations, psychosocial status, and current residential environment. Raci

Совпадение в полном тексте источника
… Medication class | Weight‐promoting medications | Alternate considerations (weight loss or weight‐neutral) Antidiabetic medications | Pioglitazone, rosiglitazone, insulin (all formulations), glyburide, glipizide, glimepiride, tolbutamide, nateglinide, repaglinide | Metformin, GLP‐1 agonists, GIP/GLP‐ …

Hallmarks of Cancer Affected by the MIF Cytokine Family.

New diagnostic methods and treatments have significantly decreased the mortality rates of cancer patients, but further improvements are warranted based on the identification of novel tumor-promoting molecules that can serve as therapeutic targets. The macrophage migration inhibitory factor (MIF) family of cytokines, comprising MIF and DDT (also known as MIF2), are overexpressed in almost all cancer types, and their high expressions are related to a worse prognosis for the patients. MIF is involved in 9 of the 10 hallmarks of cancer, and its inhibition by antibodies, nanobodies, or small synthe

Совпадение в полном тексте источника
… Indeed, glyburide and probenecid significantly reduced MIF release [ 34 ]. Previously, it was reported that MIF was necessary for the activation of the NLRP3 inflammasome [ 35 , 36 ]. …

Interactions between kidney disease and diabetes: dangerous liaisons.

BackgroundType 2 diabetes mellitus (DM) globally affects 18-20 % of adults over the age of 65 years. Diabetic kidney disease (DKD) is one of the most frequent and dangerous complications of DM2, affecting about one-third of the patients with DM2. In addition to the pancreas, adipocytes, liver, and intestines, the kidneys also play an important role in glycemic control, particularly due to renal contribution to gluconeogenesis and tubular reabsorption of glucose.MethodsIn this review article, based on a report of discussions from an interdisciplinary group of experts in the areas of endocrinolo

Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that govern the expression of genes responsible for energy metabolism, cellular development, and differentiation. Their crucial biological roles dictate the significance of PPAR-targeting synthetic ligands in medical research and drug discovery. Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies. In this review we aim to consolidate exist

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide.

Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. Previous therapeutic strategies had been mainly based on results from retrospective studies and physicians' experience. However, during the last years, the significant improvement in their genetic and pathogenic knowledge has been accompanied by a remarkable progress in their management. The relatively recent identification of the inflammasome as the crucial pathogenic mechanism causing an aberrant production of interleukin 1β (IL-1β) in the most frequent monogenic autoinflamm

Совпадение в полном тексте источника
… These new agents include glyburide, 16673-34-0, JC124, FC11A-2, parthenolide, VX-740, VX-765, Bay 11-7082, BHB, MNS, CY-09, OLT1177, oridonin, MCC950, and tranilast ( 176 ). …

From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases.

Drug repurposing, the process of identifying new therapeutic uses for existing drugs, has emerged as a cost-effective and time-saving alternative to traditional drug development. This strategy leverages the known pharmacological and safety profiles of approved or investigational drugs to accelerate their clinical application for other diseases. In recent years, repurposed drugs have played a crucial role in addressing treatment gaps in complex and multifactorial diseases such as cancer, neurodegenerative disorders and infectious diseases. This review highlights prominent examples where repurpo

Совпадение в полном тексте источника
… Drugs like edaravone, glyburide, ceftriaxone, levetiracetam and progesterone have been scrutinized for their prospective neuroprotective properties [ 32 ]. In addressing infectious diseases, DRP strategies have been applied to SARS‐CoV‐2 and its NDs. …

Кровавая добавка и болезни человека: обзор клинических испытаний.

Медицинальные свойства турмеров (Curcuma longa L.) — растения, использовавшегося на протяжении веков в качестве противовоспалительного средства, объясняются его полифеноловыми каркуминоидами, где преобладает кёркумин. Хотя «куркуминовые» добавки являются топ-продаваемыми ботаническими с перспективными доклиническими эффектами, остаются вопросы о биологической активности у человека. Для решения этой проблемы был проведен обзор аналитического исследования с целью оценки клинических испытаний человека, в ходе которых сообщалось о пероральном воздействии каркумина на результаты лечения. Eight :: п

Совпадение в полном тексте источника
… Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother. Res. 2014;28:1796–1800. doi: 10.1002/ptr.5201. 101. Panahi Y., Khalili N., Sahebi E., Namazi S., Atkin S.L., Majeed M., Sahebkar A. …

The prince and the pauper. A tale of anticancer targeted agents.

Cancer rates are set to increase at an alarming rate, from 10 million new cases globally in 2000 to 15 million in 2020. Regarding the pharmacological treatment of cancer, we currently are in the interphase of two treatment eras. The so-called pregenomic therapy which names the traditional cancer drugs, mainly cytotoxic drug types, and post-genomic era-type drugs referring to rationally-based designed. Although there are successful examples of this newer drug discovery approach, most target-specific agents only provide small gains in symptom control and/or survival, whereas others have consiste

Совпадение в полном тексте источника
… Orlistat possesses extremely low oral bioavailability, and when co-administered with other agents, has demonstrated no pharmacokinetic and pharmacodynamic interactions with drugs such as glyburide, digoxin, warfarin, oral contraceptives, nifedipine, and ethanol. …